Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,297,000 | 1,300,000 | 16,540,000 | 15,409,000 | 16,323,000 |
| Depreciation Amortization | 6,929,000 | 5,642,000 | 3,754,000 | 3,746,000 | 3,895,000 |
| Income taxes - deferred | -1,016,000 | 2,406,000 | -341,000 | -270,000 | 441,000 |
| Accounts receivable | -1,216,000 | -616,000 | -1,076,000 | -415,000 | -275,000 |
| Other Working Capital | -28,000 | 11,258,000 | -1,784,000 | 1,647,000 | -855,000 |
| Other Operating Activity | 2,235,000 | 1,066,000 | 1,674,000 | -548,000 | -819,000 |
| Operating Cash Flow | $22,201,000 | $21,056,000 | $18,767,000 | $19,569,000 | $18,710,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -467,000 | -1,447,000 | -1,959,000 | 1,000 | 917,000 |
| Net Acquisitions | -899,000 | -35,151,000 | -4,509,000 | -954,000 | -2,129,000 |
| Purchase Of Investment | -5,626,000 | -6,153,000 | -33,950,000 | -40,828,000 | -34,913,000 |
| Sale Of Investment | 4,289,000 | 28,117,000 | 35,780,000 | 34,149,000 | 24,119,000 |
| Other Investing Activity | -464,000 | -234,000 | -123,000 | -103,000 | -299,000 |
| Investing Cash Flow | $-3,167,000 | $-14,868,000 | $-4,761,000 | $-7,735,000 | $-12,305,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 80,000 | 869,000 | 111,000 | 2,416,000 | 1,863,000 |
| Debt Issued | 5,000 | 8,992,000 | 12,004,000 | 75,000 | 2,098,000 |
| Debt Repayment | -1,555,000 | -1,777,000 | -2,223,000 | -68,000 | -1,844,000 |
| Common Stock Issued | 949,000 | 1,062,000 | 1,189,000 | 1,005,000 | 1,543,000 |
| Common Stock Repurchased | -5,868,000 | -6,358,000 | -8,979,000 | -5,290,000 | -7,124,000 |
| Dividend Paid | -9,494,000 | -8,943,000 | -8,621,000 | -8,173,000 | -7,768,000 |
| Other Financing Activity | -2,627,000 | -1,518,000 | -2,032,000 | -1,101,000 | -1,267,000 |
| Financing Cash Flow | $-18,510,000 | $-7,673,000 | $-8,551,000 | $-11,136,000 | $-12,499,000 |
| Exchange Rate Effect | -241,000 | 337,000 | -215,000 | -1,489,000 | -310,000 |
| Beginning Cash Position | 17,824,000 | 18,972,000 | 13,732,000 | 14,523,000 | 20,927,000 |
| End Cash Position | 18,107,000 | 17,824,000 | 18,972,000 | 13,732,000 | 14,523,000 |
| Net Cash Flow | $283,000 | $-1,148,000 | $5,240,000 | $-791,000 | $-6,404,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,201,000 | 21,056,000 | 18,767,000 | 19,569,000 | 18,710,000 |
| Capital Expenditure | -3,670,000 | -3,279,000 | -3,226,000 | -3,463,000 | -3,714,000 |
| Free Cash Flow | 18,531,000 | 17,777,000 | 15,541,000 | 16,106,000 | 14,996,000 |